Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632)

Authors: Frances M. Cole, George S. Laszlo, Margaret C. Lunn-Halbert, Allie R. Kehret, Patrick A. Zweidler-McKay, Eduardo Rodríguez-Arbolí, David Wu, Kyle Nyberg, Junyang Li, Sheryl Y. T. Lim, Camryn M. Pettenger-Willey, Sribalaji Lakshmikanthan, Roland B. Walter

Published: 2025-03-21

DOI: 10.1038/s41375-025-02571-0

Source: Full article

---

Abstract

No abstract found.